Facebook picto   picto linkdink   picto tiwter

News & Media

Jun 14, 2016
First HIFU patient treated at Allied Urological Services in New York City

EDAP-TMS
First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm® Robotic HIFU device
First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm(R) Robotic HIFU device
Procedures Performed by Dr. Altan Ilkay
EDAP TMS SA, the global leader in therapeutic ultrasound, today announced the first prostate ablation treatment performed at a site managed by Allied Urological Services ("Allied"), an affiliate of Austin, Texas based HealthTronics, Inc. in New York, NY, using the Company's FDA-cleared Ablatherm Robotic HIFU. Dr. Altan Ilkay, a leading urologist at Allied with significant experience in minimally invasive prostate treatments, performed the procedure.
Dr. Ilkay commented: "The contemporary patient is often not satisfied with the polar choices of active surveillance (do nothing) and radical treatment with surgery or radiation. HIFU is appropriate and attractive for many of the men I see in my clinical practice. It is a versatile technology that allows for tailoring of the procedure to fit the individual patient. The Ablatherm device is a uniquely robotic device that allows for the safe ablation of tissue." He added: "The Ablatherm Robotic HIFU provides a very user-friendly interface that allows the physician to focus on the critical, clinical treatment of the patient."
The Ablatherm Robotic HIFU device used for this procedure is owned by HealthTronics, Inc., a leading provider of mobile medical technologies which is providing access to EDAP's industry-leading HIFU technology to select urologists [throughout the United States].
Russell Newman, President of HealthTronics, said, "We are excited to add EDAP's Ablatherm HIFU to our best-in-class portfolio of mobilized medical technologies and to work with our partners at Allied as the first users of the device. Ablatherm and HIFU are an important addition to our suite of technology offerings as they help us meet our commitment of providing physicians with the most innovative tools available for the treatment of their patients."
Marc Oczachowski, EDAP TMS Chief Executive Officer, added: "We are very pleased that Allied, one of the country's largest networks of urologists, has established a HIFU program incorporating the EDAP Ablatherm Robotic HIFU device. In addition, this also extends our relationship with Allied, which has been a longtime user of EDAP's unique and exclusive Lithotripsy technology, the Sonolith i-move."